Search Results

MagnetOs Easypack Putty is intended to fill bony voids or gaps of the skeletal system, i.e., the extremities, pelvis, intervertebral disc space, and posterolateral spine. The osseous defects may be surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. In the extremities, pelvis, intervertebral disc space and posterolateral spine, MagnetOs Easypack Putty may be used standalone or with autograft as a bone extender. When used in intervertebral body fusion procedures, MagnetOs Easypack Putty must also be used with an intervertebral body fusion device cleared by FDA for use with a bone void filler. MagnetOs Easypack Putty resorbs and is replaced with bone during the healing process.

MagnetOs Easypack Putty is a synthetic, resorbable, osteoconductive bone void filler for the repair of bony defects. MagnetOs Easypack Putty consists of 65-75% Tri-Calcium Phosphate (TCP - Ca3(PO4)2) and 25-35% Hydroxyapatite (HA - Caro(PO4)6 (OH)2) granules with a porous trabecular structure that resembles the interconnected porosity of human cancellous bone. The granules are covered with submicron-sized features and are premixed with a synthetic binder. New bone will be deposited on the surface of the implant. The implant resorbs and is replaced by bone during the natural process of bone remodeling.

MagnetOs Easypack Putty is a ready-for-use product. Pressure applied by manipulation allows the shaping of the devices to conform to the contours of bony defects. MagnetOs Easypack Putty is gammasterilized, comes in several sizes in block form and is sterile packaged for single use only.

The provided document is a 510(k) summary for a medical device called "MagnetOs Easypack Putty." It details the device's characteristics, indications for use, and a demonstration of its substantial equivalence to predicate devices. However, the document does not contain information regarding software or AI components, nor does it specify detailed "acceptance criteria" in the typical sense of a pass/fail threshold for an AI model's performance metrics (e.g., AUC > 0.90, Sensitivity > 95%). Instead, it discusses the device's physical properties, biocompatibility, and clinical performance related to its function as a bone void filler.

Therefore, I cannot extract the specific information requested in questions 1-9 as they pertain to AI/software acceptance criteria and performance studies. The document describes a traditional medical device (a bone void filler) where "performance" relates to its ability to resorb and promote bone healing, not to the diagnostic accuracy of an AI algorithm.

The closest analogue to "acceptance criteria" in this document is demonstrating substantial equivalence to predicates through:

• Bench testing data: analytical characterization, chemical composition, physical properties.
• Biocompatibility testing: LAL test, pyrogenicity study, sterilization.
• Clinical/Animal performance data: fusion-based imaging assessment (for interbody fusion), animal performance data for other uses.

Since the request specifically asks about "acceptance criteria and the study that proves the device meets the acceptance criteria" in the context of an AI/software device, and this document describes a physical medical device, I must state that the requested information is not available in the provided text.

Ask a specific question about this device

MagnetOs Granules is an implant intended to fill bony voids or gaps of the skeletal system, i.e., the extremities, pelvis and posterolateral spine. MagnetOs Granules may be used standalone or mixed with autograft, blood, and/or bone marrow. These osseous defects may be surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. MagnetOs Granules resorbs and is replaced with bone during the healing process.

MagnetOs Granules is a synthetic, resorbable, osteoconductive bone void filler for the repair of bony defects. MagnetOs Granules consists of 65-75% tri-calcium phosphate (TCP -Ca3(PO4)2) and 25-35% hydroxyapatite (HA - Ca10(PO4)c(OH)2) granules with a porous trabecular structure that resembles the interconnected porosity of human cancellous bone. MagnetOs Granules guide the three-dimensional regeneration of bone in the defect site into which it is implanted. New bone will be deposited on the surface of the graft when placed next to viable host bone. The graft resorbs and is replaced by bone during the natural process of bone remodeling. MagnetOs Granules is a ready-to-use product. MagnetOs Granules is provided in vials in a range of product volumes. MagnetOs Granules is gamma-sterilized and sterile packaged for single use only.

The provided text details the 510(k) summary for MagnetOs Granules, but it does not contain the specific information required to answer the prompt regarding acceptance criteria and a study proving a device meets these criteria in the context of an AI/ML medical device.

The document describes a bone void filler and its clinical evaluation (a randomized non-inferiority trial for posterolateral fusion), along with bench testing for material properties. This is a traditional medical device submission, not an AI/ML device.

Therefore, I cannot populate the table or answer most of the questions as the information is not present in the provided text. The document does not discuss:

• A table of acceptance criteria and reported device performance for an AI/ML model.
• Sample sizes used for a test set in an AI/ML context.
• Data provenance (e.g., country of origin, retrospective/prospective) for AI/ML data.
• Number of experts, their qualifications, or adjudication methods for ground truth in an AI/ML study.
• Multi-reader multi-case (MRMC) comparative effectiveness studies for AI/ML.
• Standalone performance of an algorithm.
• Training set details for an AI/ML model.

The text focuses on the substantial equivalence of a physical bone void filler device to predicate devices based on material properties, manufacturing, and clinical performance in a human trial without AI assistance.

Ask a specific question about this device

MagnetOs Easypack Putty is intended to fill bony voids or gaps of the skeletal system, i.e. posterolateral spine. In the posterolateral spine, MagnetOs Easypack Putty must be used with autograft as a bone graft extender. The osseous defects may be surgically created or the result of traumatic injury to the bone and are not intrinsic to the bony structure.

MagnetOs Easypack Putty resorbs and is replaced with bone during the healing process.

MagnetOs Easypack Putty is a synthetic, resorbable, osteoconductive bone void filler for the repair of bony defects.

MagnetOs Easypack Putty consists of 65–75% tri-calcium phosphate (TCP – Ca3(PO4)2) and 25-35% hydroxyapatite (HA - Ca10(PO4)6(OH)2) granules, premixed with a synthetic polymeric binder that provides cohesion between the granules.

New bone will be deposited on the surface of the graft when placed next to viable host bone. The graft resorbs and is replaced by bone during the natural process of bone remodeling.

MagnetOs Easypack Putty is a ready-to-use product. Pressure applied by manipulation allows users to shape MagnetOs Easypack Putty to conform to the contours of bony defects.

MagnetOs Easypack Putty is provided in open-ended syringes in a range of product volumes. MagnetOs Easypack Putty is gamma-sterilized and sterile packaged for single use only.

This document does not describe a study involving an AI/ML device, therefore, a description of acceptance criteria and the study that proves the device meets the acceptance criteria is not applicable. The provided text is a 510(k) summary for a medical device called "MagnetOs Easypack Putty," which is a resorbable calcium salt bone void filler. It details the device's characteristics, intended use, and demonstrates substantial equivalence to predicate devices through non-clinical testing and animal studies, not AI/ML performance.

Ask a specific question about this device